Our Companies

Rooted in resilience and driven by innovation, our company bridges groundbreaking science with global partners to register, distribute, and promote solutions that expand access and transform standards of care in underserved regions.

Cypress
Pharmaceutical
Group

Cypress Pharmaceutical Group Pte. Ltd. (“Cypress”), established in 2024, is a Singapore based healthcare-focused holding company that unites four dynamic operating entities: Juniper Biologics Pte. Ltd. (“Juniper”), Cedar Pharmaceuticals Pte. Ltd. (“Cedar”), Tissue Therapeutics Pte Ltd Together and Pine Pharmaceuticals Pte Ltd (“PINE”), we are committed to advancing innovative solutions that improve patient care across the pharmaceutical and healthcare ecosystem.

Cypress Pharmaceutical Group is built on a strong, collaborative structure that aligns global strategy with specialized expertise.

Together with Juniper and Cedar, we bridge science, innovation, and patient care across diverse therapeutic areas.

Our Structure

Juniper Biologics is dedicated to the development and commercialization of novel, innovative medicinal pharmaceutical products, with a focus on advancing cutting-edge therapies to address unmet medical needs. Learn More

Cedar drives innovation across pharmaceutical products, medical devices, and medical services, delivering a comprehensive healthcare offering that bridges science, technology, and patient outcomes.

Our Milestones

0

Regional Offices

0

Territory Coverage

0

Partners / Distributors

Our Companies